Alector, Inc. Company Profile

07:05 EST 19th January 2019 | BioPortfolio

Alector is a privately owned biotechnology company whose mission is to develop therapies that harness the immune system to treat neurodegenerative diseases and cancer. Alector was founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery and is backed by leading investors including OrbiMed, Polaris, Google Ventures, Topspin Partners, Mission Bay Capital, the Dementia Discovery Fund as well as AbbVie, Merck, and Amgen. For more information, please visit

News Articles [36 Associated News Articles listed on BioPortfolio]

Alector files for IPO on Nasdaq

Alector Inc. (immuno-neurology antibody therapeutics) filed for an initial public offering.

Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs

Alector, a biotech company focusing on the immune system to treat degenerative brain disorders such as Alzheimer’s disease, has filed to go public to fund human tests of its experimental therapies. ...

Poseida, Alector readying IPOs

An initial public offering has been filed by neurodegenerative disorders company Alector seeking to raise up to $150 million. -More- 

Alector raises $133m to advance Alzheimer’s disease drugs

Biotechnology firm Alector has raised $133m in a series E financing round to support further development of its clinical programmes...Read More... The post Alector raises $133m to advance Alzheimer’...

Alector starts Phase l trial of AL001 for frontotemporal dementia

Alector has commenced a Phase l INFRONT trial to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AL001 for the...Read More... The post Alector starts Phase l trial of A...

Biotech startup Alector raises $133M

Alector, a biotech startup working on treatments for neurodegenerative disorders, including Alzheimer's, raised $133 million  -More- 

Alector starts Phase I study of AL002 for Alzheimer’s disease

Alector has started a Phase I INVOKE clinical study to evaluate AL002 for the treatment of Alzheimer’s disease. The trial...Read More... The post Alector starts Phase I study of AL002 for Alzheimer...

Alector Closes $133 Million to Expand Alzheimer’s Programs

South San Francisco-based Alector closed on a Series E financing worth $133 million. The money will be used to advance the company’s clinical programs and expand its discovery platform.

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]

Alector LLC

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer’s disease, ...

Alector, Inc.

Alector is a privately owned biotechnology company whose mission is to develop therapies that harness the immune system to treat neurodegenerative diseases and cancer. Alector was...

More Information about "Alector, Inc." on BioPortfolio

We have published hundreds of Alector, Inc. news stories on BioPortfolio along with dozens of Alector, Inc. Clinical Trials and PubMed Articles about Alector, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alector, Inc. Companies in our database. You can also find out about relevant Alector, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record